Breaking News, Collaborations & Alliances

BioSeek Extends Merck Serono Pact

Asterand unit expands access to BioMAP Platform

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

BioSeek, LLC, a subsidiary of Asterand, has signed a new, three-year collaboration agreement with Merck Serono, a division of Merck KGaA, expanding the companies’ 2009 agreement. BioSeek will use its BioMAP platform to evaluate Merck Serono small molecule compounds and proteins across multiple therapeutic areas to support the selection of candidates for preclinical development. BioMAP Systems are primary cell-based models of human disease biology, designed to replicate cell and pathway interact...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters